Self Expanding TAVR via Percutaneous Femoral Access in Extremely High Risk Patient

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Self Expanding TAVR via Percutaneous Femoral Access in Extremely High Risk Patient

By Mount Sinai Structural Heart Live Cases FEATURING Samin Sharma

611 views

April 22, 2015

An 84 year-old male presented with NYHA class III heart failure associated with progressive weakness ...
read more ↘ and dyspnea. TTE revealed severe AS, peak/mean aortic gradient = 63/42 mmHg, AVA = 0.8 sq cm, aortic peak velocity = 4.0 m/sec and LVEF 60%. CT angio showed minimum diameters of 0.8 x 0.7 cm for right and 0.9 x 1.0 cm for the left common femoral arteries and aortic annulus of 2.2 x 2.8 cm (average 2.5). The STS risk mortality is 2.6% and the Logistic Euroscore mortality is 18.1%. Patient was determined to be extreme risk for surgical AVR due to localized lung cancer with projected life expectancy of 2-3 years. Patient is now planned for CoreValve TAVR (29mm) via percutaneous femoral access under conscious sedation.

December 9, 2014 Webcast Video
↖ read less

0 Comments